Nagai Takahiro, Sunami Yoko, Kato Risa, Sugai Megumi, Takahara Makoto, Ohta Kentaro, Fujinaka Hidehiko, Goto Kiyoe, Okanura Osamu, Nakajima Takashi, Ozawa Tetsuo
Department of Neurology, National Hospital Organization Niigata National Hospital, Kashiwazaki, Japan.
Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Case Rep Neurol. 2021 Feb 15;13(1):84-91. doi: 10.1159/000512404. eCollection 2021 Jan-Apr.
Spastic paraplegia type 4 (SPG4) is the most common type of hereditary spastic paraplegia (HSP) caused by the mutations in the gene, which encodes a microtubule-severing protein named spastin. Spastin regulates the number and mobility of microtubules and is essential for axonal outgrowth and neuronal morphogenesis. Herein, we report a patient with SPG4 harboring a novel donor splice site mutation in the gene (c.1616+1dupG). Although SPG4 usually manifests itself as a pure form of HSP, this patient exhibited a slow progressive cognitive decline and also developed narcolepsy type 2 (narcolepsy without cataplexy) prior to the onset of SPG4. Recently, cognitive decline has attracted attention as a main non-motor symptom of SPG4. However, this is the first reported case of a patient developing both SPG4 and narcolepsy, although it remains unclear whether the manifestation of the two diseases is a coincidence or an association. In this report, we describe the clinical symptoms and genetic background of the patient.
4型痉挛性截瘫(SPG4)是由该基因突变引起的最常见的遗传性痉挛性截瘫(HSP)类型,该基因编码一种名为痉挛蛋白的微管切断蛋白。痉挛蛋白调节微管的数量和移动性,对轴突生长和神经元形态发生至关重要。在此,我们报告一名患有SPG4的患者,其该基因存在一个新的供体剪接位点突变(c.1616+1dupG)。虽然SPG4通常表现为单纯形式的HSP,但该患者在SPG4发病前出现了缓慢进展的认知衰退,还患上了2型发作性睡病(无猝倒的发作性睡病)。最近,认知衰退作为SPG4的主要非运动症状受到了关注。然而,这是首例同时患有SPG4和发作性睡病的患者报告,尽管尚不清楚这两种疾病的表现是巧合还是存在关联。在本报告中,我们描述了该患者的临床症状和基因背景。